- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1060EUR$1,200USD£929GBP
€1325EUR$1,500USD£1,161GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1413EUR$1,600USD£1,238GBP
€1767EUR$2,000USD£1,548GBP
- Report
- March 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,475GBP
- Report
- August 2025
- 150 Pages
Global
From €2518EUR$2,850USD£2,206GBP
€3401EUR$3,850USD£2,980GBP
- Report
- July 2025
- 350 Pages
Global
From €4372EUR$4,949USD£3,830GBP
- Report
- June 2025
- 400 Pages
Global
From €4372EUR$4,949USD£3,830GBP
- Report
- April 2025
- 192 Pages
Global
From €4413EUR$4,995USD£3,866GBP
- Report
- July 2025
- 120 Pages
Global
From €5256EUR$5,950USD£4,605GBP
- Report
- December 2025
- 487 Pages
Global
From €5168EUR$5,850USD£4,528GBP
- Report
- December 2025
- 563 Pages
Global
From €5168EUR$5,850USD£4,528GBP
- Report
- November 2025
- 185 Pages
Global
From €3975EUR$4,500USD£3,483GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2464EUR$2,789USD£2,159GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2464EUR$2,789USD£2,159GBP
- Report
- July 2025
- 175 Pages
Global
From €3966EUR$4,490USD£3,475GBP
- Report
- July 2024
- 150 Pages
Global
From €5256EUR$5,950USD£4,605GBP
- Report
- May 2023
- 260 Pages
Global
From €2341EUR$2,650USD£2,051GBP
- Report
- June 2024
- 200 Pages
Global
From €5618EUR$6,360USD£4,923GBP
€7023EUR$7,950USD£6,153GBP
- Report
- June 2024
- 200 Pages
Global
From €5618EUR$6,360USD£4,923GBP
€7023EUR$7,950USD£6,153GBP
- Report
- January 2022
- 60 Pages
Global
From €2792EUR$3,160USD£2,446GBP
€3489EUR$3,950USD£3,057GBP
- Report
- May 2024
- 137 Pages
Global
From €4880EUR$5,524USD£4,276GBP
€5741EUR$6,499USD£5,030GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more